PLoS ONE (Jan 2012)

Down-regulation of neogenin accelerated glioma progression through promoter Methylation and its overexpression in SHG-44 Induced Apoptosis.

  • Xinmin Wu,
  • Yunqian Li,
  • Xilin Wan,
  • Tabitha Mlowoka Kayira,
  • Rangjuan Cao,
  • Xingda Ju,
  • Xiaojuan Zhu,
  • Gang Zhao

DOI
https://doi.org/10.1371/journal.pone.0038074
Journal volume & issue
Vol. 7, no. 5
p. e38074

Abstract

Read online

BackgroundDependence receptors have been proved to act as tumor suppressors in tumorigenesis. Neogenin, a DCC homologue, well known for its fundamental role in axon guidance and cellular differentiation, is also a dependence receptor functioning to control apoptosis. However, loss of neogenin has been reported in several kinds of cancers, but its role in glioma remains to be further investigated.Methodology/principal findingsWestern blot analysis showed that neogenin level was lower in glioma tissues than in their matching surrounding non-neoplastic tissues (n = 13, pConclusions/significanceThese observations recapitulated the proposed role of neogenin as a tumor suppressor in gliomas and we suggest its down-regulation owing to promoter methylation is a selective advantage for glioma genesis, progression and recurrence. Furthermore, the induction of apoptosis in SHG-44 cells after overexpression of neogenin, indicated that neogenin could be a novel target for glioma therapy.